ÂÜÀòÂÒÂ×

Paul Brunetta, MD, is Senior Vice President of Clinical and Translational Science at Sana Biotechnology and Adjunct Associate Professor in the Pulmonary and Critical Care Division at University of California, San Francisco. He is a pulmonary and critical care physician with 17 years of experience in biotechnology drug development.

Most recently, Paul served as Senior Vice President of Translational Science at Juno Therapeutics. Prior to Juno, he was at Genentech for 15 years serving in roles of increasing responsibility. At Genentech, he was responsible for designing, monitoring and implementing clinical trials in autoimmune drug development spanning phase I-IV in neurology, nephrology, rheumatology, immunology, pulmonary medicine and solid organ transplantation. Paul also directed the Genentech Clinical Research Fellowship for 12 years.

He earned his BA in biology at Johns Hopkins University and his MD at Tufts University School of Medicine.